NPC1 and nonpapillary renal cell carcinoma: Given that trafficking of de novo synthetized cholesterol in normal cells is not affected by pharmacological or genetic inhibition of NPC1 [22], we anticipated that ccRCC cells would be particularly sensitive to the inhibition of NPC-1-regulated endosomal cholesterol trafficking.